{
  "package" : "hl7.terminology.r5@6.3.0",
  "definition" : "Use when not enough clinical trial data published by the Clinical and Laboratory Standards Institutes (CLSI) is available to establish the breakpoints for susceptible / intermediate and resistant.",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#status",
    "code" : "status",
    "valueCode" : "active"
  }, {
    "_uri" : "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id",
    "code" : "internalId",
    "valueCode" : "23886"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "subsumedBy",
    "valueCode" : "_ObservationInterpretationSusceptibility"
  } ],
  "codesystem" : "701017a8-e717-5351-8c56-15a0abeb863d",
  "concept_id" : "19e5ae51-a7dd-59c8-af80-e15c70b13ae0",
  "ancestors" : {
    "NCL" : 0,
    "_ObservationInterpretationSusceptibility" : 1
  },
  "id" : "e6bceabc-073d-466d-97ff-9e13b614af6e",
  "code" : "NCL",
  "display" : "No CLSI defined breakpoint",
  "version" : "3.0.0"
}